相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 expression by Tumor Proportion Score (TPS) and Combined Positive Score (CPS) are similar in non-small cell lung cancer (NSCLC)
Pedro De Marchi et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review
Keisuke Onoi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer
Karina Kulangara et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M. Conroy et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer
Katharina Kriegsmann et al.
PATHOLOGY (2019)
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Narjust Duma et al.
MAYO CLINIC PROCEEDINGS (2019)
Fine-needle aspiration cytology of non-small cell lung carcinoma: A paradigm shift
Pranab Dey et al.
DIAGNOSTIC CYTOPATHOLOGY (2019)
A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
Anna Karlsson et al.
SCIENTIFIC REPORTS (2019)
PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
Hyojin Kim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma
Khairunisa Ahmad Affandi et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2018)
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Robert Brody et al.
LUNG CANCER (2017)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases
Grzegorz T. Gurda et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer
Ming-Hui Ao et al.
HUMAN PATHOLOGY (2014)
Cytosine Deamination Is a Major Cause of Baseline Noise in Next-Generation Sequencing
Guoli Chen et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
p40: A p63 Isoform Useful for Lung Cancer Diagnosis - A Review of the Physiological and Pathological Role of p63
Ana Rita Nobre et al.
ACTA CYTOLOGICA (2013)
TTF-1 and Napsin A Do Not Differentiate Metastatic Lung Adenocarcinomas From Primary Esophageal Adenocarcinomas Proposal of a Novel Staining Panel
Kanwaijit S. Aulakh et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung
J. Ye et al.
BIOTECHNIC & HISTOCHEMISTRY (2012)
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
Justin A. Bishop et al.
MODERN PATHOLOGY (2012)
Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6
Sanjay Mukhopadhyay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology A Retrospective Study of 103 Cases With Surgical Correlation
Luisella Righi et al.
CANCER (2011)
TTF-1 and Napsin A Double Stain A Useful Marker for Diagnosing Lung Adenocarcinoma on Fine-Needle Aspiration Cell Blocks
Nazneen Fatima et al.
CANCER CYTOPATHOLOGY (2011)
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung
Jiqing Ye et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma
Justin A. Bishop et al.
HUMAN PATHOLOGY (2010)
Value of P63 and CK5/6 in Distinguishing Squamous Cell Carcinoma From Adenocarcinoma in Lung Fine-Needle Aspiration Specimens
Said Khayyata et al.
DIAGNOSTIC CYTOPATHOLOGY (2009)
分享论文
